Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Advanced Enzyme Technologies Limited Regulatory Filings 2025

Feb 3, 2025

62369_rns_2025-02-03_073b64b3-2c05-4f7f-9a4f-8594535df752.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

Date: February 03, 2025

BSE Limited National Stock Exchange of India Ltd. Department of Corporate Affairs Exchange Plaza, Plot No. C/1, G Block P. J. Towers, Dalal Street, Bandra-Kurla Complex, Bandra (E) Mumbai- 400 001 Mumbai- 400 051 Scrip ID-540025 Scrip Code-ADVENZYMES

Dear Sir,

Sub: Intimation on Conference call – Un-audited Financial Results for the quarter and nine months ended December 31, 2024 under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the Company will host a Conference call for Analysts and Investors to discuss the un-audited financial results of the Company for the quarter and nine months ended December 31, 2024 on Wednesday, February 12, 2025 at 04:00 p.m. (IST) as per the details provided in the Annexure.

The aforesaid information is also being uploaded on the website of the Company.

Kindly take same on your records.

Thanking you, Yours Faithfully,

For Advanced Enzyme Technologies Limited

SANJAY Digitally signed PRAKASH by SANJAY PRAKASH BASANTA BASANTANI Date: 2025.02.03 NI 16:12:19 +05'30'


Sanjay Basantani Company Secretary and Head – Legal

Encl.: As above

==> picture [202 x 53] intentionally omitted <==

==> picture [594 x 111] intentionally omitted <==

----- Start of picture text ----- Advanced Enzyme Technologies Limited will host a conference callfor analysts and investors to discuss the financial results for theQuarter & Nine Months ended 31 [st] December 2024----- End of picture text -----

Management will be represented by:

Mr. V.L Rathi – Chairman & Non-Executive Director

Mr. Mukund Kabra - Whole-time Director

Mr. Beni Prasad Rauka - Chief Financial Officer

Ms. Rasika Rathi - Non-Executive Director

(Vice President, SEB USA)

Ms. Reshma Rathi – Vice President Operations

(SEB USA)

Conference Dial-in Numbers

Please dial the numbers at least 5 -10 minutes prior to the conference schedule to ensure that you are connected to your call in time Primary Number: + 91 22 6280 1403 / +91 22 7115 8304

The numbers listed are universally accessible from all networks and all countries below

Toll Free Number:

USA: 18667462133 UK: 08081011573 Singapore: 8001012045 Hong Kong: 800964448

Pre-register to avoid wait time:

==> picture [203 x 39] intentionally omitted <==

----- Start of picture text ----- Registration Link----- End of picture text -----

Advanced Enzyme Technologies Limited

RSVP Advanced Enzyme Technologies Limited Ronak Saraf Investor Relations [email protected] +91 86578 64146

Regd. Office: 5[th] Floor, ‘A’ Wing, Sun Magnetica, Louiswadi, Thane (W) ‐400 604 | Tel.: +91 22 41703200 Website: www.advancedenzymes.com CIN No: L24200MH1989PLC051018